• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIX1 和 EWS/FLI1 共同调控尤文肉瘤中的抗转移基因网络。

SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma.

机构信息

Medical Scientist Training Program, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.

Pharmacology Program, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.

出版信息

Nat Commun. 2023 Jul 19;14(1):4357. doi: 10.1038/s41467-023-39945-w.

DOI:10.1038/s41467-023-39945-w
PMID:37468459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10356808/
Abstract

Ewing sarcoma (ES), which is characterized by the presence of oncogenic fusion proteins such as EWS/FLI1, is an aggressive pediatric malignancy with a high rate of early dissemination and poor outcome after distant spread. Here we demonstrate that the SIX1 homeoprotein, which enhances metastasis in most tumor types, suppresses ES metastasis by co-regulating EWS/FLI1 target genes. Like EWS/FLI1, SIX1 promotes cell growth/transformation, yet dramatically inhibits migration and invasion, as well as metastasis in vivo. We show that EWS/FLI1 promotes SIX1 protein expression, and that the two proteins share genome-wide binding profiles and transcriptional regulatory targets, including many metastasis-associated genes such as integrins, which they co-regulate. We further show that SIX1 downregulation of integrins is critical to its ability to inhibit invasion, a key characteristic of metastatic cells. These data demonstrate an unexpected anti-metastatic function for SIX1, through coordinate gene regulation with the key oncoprotein in ES, EWS/FLI1.

摘要

尤因肉瘤 (ES) 的特征是存在致癌融合蛋白,如 EWS/FLI1,是一种具有高早期扩散率和远处转移后不良预后的侵袭性儿科恶性肿瘤。在这里,我们证明 SIX1 同源蛋白通过共同调节 EWS/FLI1 靶基因抑制 ES 转移。与 EWS/FLI1 一样,SIX1 促进细胞生长/转化,但显著抑制迁移和侵袭,以及体内转移。我们表明 EWS/FLI1 促进 SIX1 蛋白表达,并且这两种蛋白质具有全基因组结合图谱和转录调节靶标,包括许多与转移相关的基因,如整合素,它们共同调节。我们进一步表明,SIX1 下调整合素对于其抑制侵袭的能力至关重要,这是转移细胞的一个关键特征。这些数据表明 SIX1 通过与 ES 中的关键癌蛋白 EWS/FLI1 进行协调基因调节,具有意外的抗转移功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/10294f935b16/41467_2023_39945_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/0b2d9d515f2b/41467_2023_39945_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/9dc225deb8eb/41467_2023_39945_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/4944353d774a/41467_2023_39945_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/77fb77dff543/41467_2023_39945_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/dca8f767e8f4/41467_2023_39945_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/dd17fd765af8/41467_2023_39945_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/8fabf1088085/41467_2023_39945_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/21c31201a775/41467_2023_39945_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/10294f935b16/41467_2023_39945_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/0b2d9d515f2b/41467_2023_39945_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/9dc225deb8eb/41467_2023_39945_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/4944353d774a/41467_2023_39945_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/77fb77dff543/41467_2023_39945_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/dca8f767e8f4/41467_2023_39945_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/dd17fd765af8/41467_2023_39945_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/8fabf1088085/41467_2023_39945_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/21c31201a775/41467_2023_39945_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c2/10356808/10294f935b16/41467_2023_39945_Fig9_HTML.jpg

相似文献

1
SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma.SIX1 和 EWS/FLI1 共同调控尤文肉瘤中的抗转移基因网络。
Nat Commun. 2023 Jul 19;14(1):4357. doi: 10.1038/s41467-023-39945-w.
2
EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma.EWS::FLI1 和 HOXD13 控制尤文肉瘤肿瘤细胞的可塑性。
Clin Cancer Res. 2022 Oct 14;28(20):4466-4478. doi: 10.1158/1078-0432.CCR-22-0384.
3
High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.尤因肉瘤细胞中的高通量RNA干扰筛选确定富含亮氨酸重复序列和WD重复结构域1(LRWD1)是EWS-FLI1驱动的细胞活力的调节因子。
Gene. 2017 Jan 5;596:137-146. doi: 10.1016/j.gene.2016.10.021. Epub 2016 Oct 17.
4
EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.EWS-FLI1 通过与 Foxq1 合作在小鼠尤文肉瘤中调节转录程序。
Cancer Sci. 2018 Sep;109(9):2907-2918. doi: 10.1111/cas.13710. Epub 2018 Jul 18.
5
Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma.USP9X 抑制作用消除 EWS-FLI1 可抑制尤文肉瘤中癌细胞的生长。
Cancer Lett. 2023 Jan 1;552:215984. doi: 10.1016/j.canlet.2022.215984. Epub 2022 Oct 29.
6
Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing's sarcoma in vitro.EWS-FLI1 融合蛋白的连接区在体外具有 Ewing 肉瘤的显性负效应。
BMC Cancer. 2012 Nov 12;12:513. doi: 10.1186/1471-2407-12-513.
7
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.miR-30a-5p 将 EWS-FLI1 和 CD99 这两个尤文肿瘤的主要治疗靶点联系在一起。
Oncogene. 2013 Aug 15;32(33):3915-21. doi: 10.1038/onc.2012.403.
8
EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.EWS-FLI1扰乱MRTFB/YAP-1/TEAD靶基因调控,抑制尤文肉瘤中的细胞骨架自调节反馈。
Oncogene. 2017 Oct 26;36(43):5995-6005. doi: 10.1038/onc.2017.202. Epub 2017 Jul 3.
9
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation.EWS-FLI1 介导的增强子激活的拮抗作用导致尤文肉瘤中 ETV6 的依赖性。
Nat Cell Biol. 2023 Feb;25(2):298-308. doi: 10.1038/s41556-022-01060-1. Epub 2023 Jan 19.
10
EWS-FLI1 and Activator Protein-1 (AP-1) Reciprocally Regulate Extracellular-Matrix Proteins in Ewing sarcoma Cells.EWS-FLI1 和激活蛋白 1(AP-1)在尤文肉瘤细胞中相互调节细胞外基质蛋白。
Int J Mol Sci. 2024 Aug 6;25(16):8595. doi: 10.3390/ijms25168595.

引用本文的文献

1
Integrative analysis of T cell-associated markers in Ewing sarcoma reveals prognostic signatures and immune dynamics.尤因肉瘤中T细胞相关标志物的综合分析揭示了预后特征和免疫动态。
Front Immunol. 2025 Jun 18;16:1586544. doi: 10.3389/fimmu.2025.1586544. eCollection 2025.
2
ETS-1 in tumor immunology: implications for novel anti-cancer strategies.肿瘤免疫学中的ETS-1:对新型抗癌策略的启示
Front Immunol. 2025 Mar 20;16:1526368. doi: 10.3389/fimmu.2025.1526368. eCollection 2025.
3
Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis.

本文引用的文献

1
EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma.EWS/FLI 介导的 3D 染色质重编程促进尤文肉瘤中改变的转录状态。
Nucleic Acids Res. 2022 Sep 23;50(17):9814-9837. doi: 10.1093/nar/gkac747.
2
SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state.SIX1 将肌源性转录因子重新编程以维持横纹肌肉瘤的未分化状态。
Cell Rep. 2022 Feb 1;38(5):110323. doi: 10.1016/j.celrep.2022.110323.
3
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis.
通过多组学和多数据集分析确定整合素为骨肉瘤潜在的预后标志物。
NPJ Precis Oncol. 2025 Jan 17;9(1):19. doi: 10.1038/s41698-024-00794-5.
4
Implications of ITCH-mediated ubiquitination of SIX1 on CDC27-cyclinB1 signaling in nasopharyngeal carcinoma.ITC 介导的 SIX1 泛素化对鼻咽癌中 CDC27-cyclinB1 信号的影响。
Sci Rep. 2024 Oct 15;14(1):24140. doi: 10.1038/s41598-024-73239-5.
5
Cooperation between SIX1 and DHX9 transcriptionally regulates integrin-focal adhesion signaling mediated metastasis and sunitinib resistance in KIRC.SIX1 和 DHX9 的合作转录调控整合素-焦点黏附信号,介导 KIRC 的转移和舒尼替尼耐药。
Oncogene. 2024 Sep;43(39):2951-2969. doi: 10.1038/s41388-024-03126-w. Epub 2024 Aug 22.
6
Advances in ex vivo expansion of hematopoietic stem and progenitor cells for clinical applications.用于临床应用的造血干细胞和祖细胞体外扩增的进展。
Front Bioeng Biotechnol. 2024 May 23;12:1380950. doi: 10.3389/fbioe.2024.1380950. eCollection 2024.
鉴定一种小分子抑制剂,该抑制剂能破坏 SIX1/EYA2 复合物、上皮间质转化和转移。
Cancer Res. 2020 Jun 15;80(12):2689-2702. doi: 10.1158/0008-5472.CAN-20-0435. Epub 2020 Apr 27.
4
Dynamic changes in cis-regulatory occupancy by Six1 and its cooperative interactions with distinct cofactors drive lineage-specific gene expression programs during progressive differentiation of the auditory sensory epithelium.在听觉感觉上皮的渐进分化过程中,Six1 的顺式调控区占据的动态变化及其与不同辅助因子的协同相互作用,驱动了谱系特异性基因表达程序。
Nucleic Acids Res. 2020 Apr 6;48(6):2880-2896. doi: 10.1093/nar/gkaa012.
5
EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma.EWS-FLI1 介导的 tenascin-C 表达通过整合素 α5β1 介导的 YAP 激活靶向 MALAT1,从而促进尤文肉瘤的肿瘤进展。
Br J Cancer. 2019 Nov;121(11):922-933. doi: 10.1038/s41416-019-0608-1. Epub 2019 Oct 25.
6
Nonparametric expression analysis using inferential replicate counts.使用推断重复计数的非参数表达分析。
Nucleic Acids Res. 2019 Oct 10;47(18):e105. doi: 10.1093/nar/gkz622.
7
Epithelial-to-mesenchymal transition and drug resistance: transitioning away from death.上皮-间质转化与耐药性:摆脱死亡的转变
J Thorac Dis. 2019 Jun;11(6):E82-E85. doi: 10.21037/jtd.2019.06.11.
8
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells.变构 EYA2 磷酸酶抑制剂的结构和功能分析,该抑制剂在人类肺癌细胞中有靶标效应。
Mol Cancer Ther. 2019 Sep;18(9):1484-1496. doi: 10.1158/1535-7163.MCT-18-1239. Epub 2019 Jul 8.
9
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Metascape 为系统水平数据集的分析提供了面向生物学家的资源。
Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6.
10
SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.SIX1 通过激活 PI3K/AKT 信号降低 PTEN 的表达,从而促进骨肉瘤细胞增殖和肿瘤发生。
Biomed Pharmacother. 2018 Sep;105:10-17. doi: 10.1016/j.biopha.2018.04.028. Epub 2018 May 26.